Target intelligence / Profile preview

CD112 receptor (CD112R)

Target
CD112R
Molecular classification
Poliovirus receptor (PVR) family, Nectin and nectin-like family, Single-pass transmembrane protein, Receptor
01

Overview

CD112R is a co-inhibitory immune checkpoint receptor preferentially expressed on immune cells, especially NK cells, NKT cells, and T cells. Its primary ligand is CD112 (Nectin-2). CD112R inhibits T cell receptor–mediated signaling, leading to reduced cytokine production and proliferation in T cells. Targeting the CD112R–CD112 axis can enhance anti-tumor immunity, making it a potential target for cancer immunotherapy.

Other names
PVRIGPoliovirus Receptor Related Immunoglobulin Domain Protein
02

Mechanism of action

Checkpoint blockade; disruption of CD112R-CD112 interaction enhances anti-tumor immunity

03

Biological functions

Immune checkpointInhibits T cell receptor–mediated signalingSuppresses T-cell activationModulates immune responses
04

Disease associations

CancerImmunosuppression

Beyond the preview

Go deeper on CD112 receptor (CD112R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD112 receptor (CD112R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call